Maria Halasz, chief executive for Cellmid, speaks with Proactive Investors.
Investor deep dive
Cellmid driving towards profitability with anti-ageing product range
Cellmid's Maria Halasz talks outstanding study results and growing expansion plans
Quick facts: Cellmid Limited
Price: 0.205 AUD
Market Cap: $17.14 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Cellmid Limited named herein, including the promotion by the Company of Cellmid Limited in any Content on the Site, the Company receives from...FOR OUR FULL DISCLAIMER CLICK HERE